The A4 study: Now is the time to join the fight to prevent Alzheimer's disease.

News

Share the A4 StudyShare on Facebook
Facebook
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin

Alzheimer’s Study in People at Risk, a Response to FDA Call for Early Research, Now Recruiting

September 16, 2016
Off
Alzheimer’s News Today
READ MORE

New Alzheimer’s Disease Drug A4 May Help People At Risk

June 22, 2016
Off
Today Show
READ MORE

Can Alzheimer’s be Stopped?

June 09, 2016
Off
PBS – NOVA
READ MORE

New Trial to Treat Alzheimer’s Seen as “Game Changing”

June 09, 2016
Off
CBS
READ MORE

Harvard Prevention Trial Studies Tau, Alzheimer’s Other Protein

June 08, 2016
Off
Reuters
READ MORE

Peeking into Healthy Brains to See if Alzheimer’s is Brewing

June 07, 2016
Off
Associated Press
READ MORE

Alzheimer’s Diagnosis Expanding to Catch Early Warning Signs

June 06, 2016
Off
NPR Shots Blog
READ MORE

Major New Study Tests Drug to Prevent Alzheimer’s Disease

May 07, 2016
Off
AARP blog
READ MORE

Would You Want to Know if You’re Likely to Get Alzheimer’s Disease?

May 06, 2016
Off
Washington Post
READ MORE
12345

Categories

National Media

Local Media

Journal Articles

A4 Study Organizers

The A4 Study is a landmark public-private partnership, funded by the National Institute on Aging/NIH, Eli Lilly and Company, and several philanthropic organizations. The A4 trial is coordinated by the University of Southern California’s Alzheimer’s Therapeutic Research Institute, with study sites in multiple locations.

Quick Search

Share the A4 Study

©2019 A4 Study